Abstract
The Society for NeuroOncology (SNO) is an international organization that brings together clinicians and researchers with an interest in central nervous system malignancies. Although a large part of its focus is on diagnosis and management of malignant brain tumours, this year’s SNO conference provided valuable educational and scientific sessions on other malignant and non-malignant tumours affecting nerves and supporting cells throughout the body. Of note, SNO 2023 gave attendees in-depth opportunities to hear from world-renowned experts about the clinical impact and best practices for diagnosis and management of neurofibromatosis type 1 (NF1), a single-gene tumour predisposition syndrome with a diverse clinical presentation. This report will focus on the insights and data presented at SNO 2023 into the current state of the art in understanding and managing two key types of NF1-associated tumours: plexiform neurofibromas and cutaneous neurofibromas.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
